TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
C-Rad AB Class B ( ($SE:CRAD.B) ) has provided an update.
C-RAD AB has announced a decision to repurchase up to 597,000 of its own class B shares, valued at a maximum of SEK 20 million, as part of a strategy to optimize its capital structure. This move, authorized by the 2025 Annual General Meeting, aims to reduce share capital by canceling the repurchased shares, potentially impacting the company’s financial targets and shareholder returns.
The most recent analyst rating on ($SE:CRAD.B) stock is a Hold with a SEK35.00 price target. To see the full list of analyst forecasts on C-Rad AB Class B stock, see the SE:CRAD.B Stock Forecast page.
More about C-Rad AB Class B
C-RAD AB is a global leader in surface-guided radiation therapy (SGRT), developing imaging solutions for radiation therapy that ensure accurate dose delivery to tumors while protecting healthy tissue. Their technology utilizes high-speed 3D cameras and augmented reality to enhance patient setup and monitor motion during treatment, ensuring safety and comfort without additional imaging doses.
Average Trading Volume: 34,690
Technical Sentiment Signal: Hold
Current Market Cap: SEK1.12B
Learn more about CRAD.B stock on TipRanks’ Stock Analysis page.